Both in Pharmaceuticals
Tilray Brands vs Relmada Therapeutics
Over the past year TLRY returned −81.1% and RLMD returned +58.4%; their daily moves had a correlation of 0.02.
TLRY −81.1% RLMD +58.4%Growth of $1, one year, split-adjusted
| Metric | TLRY | RLMD |
|---|---|---|
| Price | $2.53 | $3.58 |
| Market cap | $373.9M | $381.9M |
| Today | −4.17% | +4.07% |
| 1 month | −29.1% | −2.2% |
| 6 months | −58.9% | −53.1% |
| Year to date | −72.0% | −25.9% |
| 1 year | −81.4% | +46.1% |
| Revenue growth (YoY) | +22.7% | — |
| Gross margin | 30.1% | — |
| Net margin | −16.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.4× | — |
| Net cash | $16.6M | $217.7M |
| Dividend yield | — | — |
| Volatility (60d) | 47.1% | 58.2% |
| Short % of float | 14.6% | 14.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).